Optometrists in Carson City, NV Accepting Medicare

45 Optometrists found. Showing 41 - 45

Vision Consultants Optometrist Medicare: Not Enrolled in Medicare Practice Location: 201 Koontz Ln, Carson City, NV 89701 Phone: 775-883-3622

Dr. Farnaz Khankhanian, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3790 Us Highway 395 S, Ste 407, Carson City, NV 89705 Phone: 775-267-2012    Fax: 775-267-2010

Dr. James William Pittman Jr., OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3770 Us Highway 395 S, Carson City, NV 89705 Phone: 775-267-5611    Fax: 775-267-9087

Dr. Thomas Joseph Gibbons, O.D. - OPTOMETRIST Optometrist Medicare: Medicare Enrolled Practice Location: 444 S Division St, Carson City, NV 89703 Phone: 775-882-5963    Fax: 775-882-5371

James S Herzman Jr., OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1987 N Carson St Ste 5, Carson City, NV 89701 Phone: 775-883-2015    Fax: 775-883-5805

News Archive

Acucela to present data on its ACU-4429 visual cycle modulator for dry AMD

Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that data for the company's novel visual cycle modulator, ACU-4429, a potential oral treatment for dry age-related macular degeneration (dry AMD), will be featured at the 8th International Symposium on Ocular Pharmacology and Therapeutics (ISOPT) being held in Rome, Italy from December 3 to 6, 2009.

Diagnostic imaging gets cardiovascular eye

Imaging has become a heated topic, embroiling cardiologists and more than 20 other medical specialists in a debate about tests selected and who performs and interprets them. In San Francisco on August 11-13, the American College of Cardiology is tackling this tough topic in its first-annual Integrated Cardiovascular Imaging Conference.

Shanghai Biolaxy receives IND approval for insulin formulation to treat diabetes

Shanghai Biolaxy announced the Chinese State Food & Drug Administration (SFDA) has approved the investigational new drug application (IND) for its oral insulin project (Nodlin), an innovative insulin formulation to treat diabetes. This IND approval allows Biolaxy to initiate its first phase I clinical study.

Olympus and Cytosurge collaborate to deliver a complete single-cell and CRISPR genetic manipulation solution in the Americas

Olympus, a leading manufacturer of high-end research microscopes, and Cytosurge, a precision manufacturer of cell manipulation technologies, have entered a co-marketing agreement to become a complete system provider to the scientific community's growing need for next-generation single-cell and CRISPR genetic manipulation solutions.

Calcium linked to lower risk of cancer in women

Women with higher intake of calcium appear to have a lower risk of cancer overall, and both men and women with high calcium intakes have lower risks of colorectal cancer and other cancers of the digestive system, according to a report in the February 23 issue of Archives of Internal Medicine.

Read more Medical News

› Verified 2 days ago

• 1
• 2
• 3(current)